Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right Basher, brah your desperation is showing despite no one listening
Just proved the Basher Point, Happy Weekend Brah.
:
Funny how paid known Bashers seem not to care about CANB or any other OTC stocks but yet comment even on the weekends, can’t be more deceiving.
CANB 3023 and Beyond…Period.
Funny how paid known Bashers seem not to care about CANB or any other OTC stocks but yet comment even on the weekends, can’t be more deceiving.
CANB 3023 and Beyond…Period.
More like the Basher Clown bullshit, it seems to fall on Deaf Ears, but it makes for a good laugh Brah
Actually that Basher opinion has been said 4 years ago, it’s not working. CANB investors have been seriously Loading during these couple of weeks at these Oversold Levels…Period.
Looks like CANB is going to be around A Long Time.
Can’t wait for the next Record Breaking Quarter Earnings to be released shortly ;)
Sorry Basher, We are not selling our shares, please take your basher comments to another bd, these are held with a Kung Fu Grip.
:
Basher Clowns to be wary of:
Waterchaser
PennyMaster
They want you to sell your shares…
Watch, they will bash relentlessly to get you to sell your shares.
Not happening, Sorry.
Basher Clowns to be wary of:
Waterchaser
PennyMaster
They want you to sell your shares…
Watch, they will bash relentlessly to get you to sell your shares.
Don’t do it.
Yep, Excellent News BG.
Also looking forward to Another Record Quarter by CANB $$$$$
CANB- 2023 And Beyond.
Brah, this is the CANB bd, not HIRU bd. Bashing confusion happens after a certain age, too funny 😂
More Great News from CANB, no wonder Accumulation continues at these Oversold Levels:
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
Can B Corp
Thu, July 20, 2023 at 9:00 AM EDT
In this article:
CANB
Recommendation Rating
Buy
Can B Corp
Can B Corp
Processing Has Already Started
HICKSVILLE, NY, July 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its newly awarded contract with One Bad Moon Rising and purchase of 1.8 million pounds of biomass.
To initially service the contract, Can B purchased 1.8 million pounds of biomass that is ready for immediate processing. The biomass is stored indoors in 1,000-pound supersacks in Ft. Morgan, Colorado (80 miles northeast of Denver).
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are very excited for this new opportunity with One Bad Moon Rising. We were able to purchase the biomass with a market price of $2.7 million by issuing Rule 144 restricted stock in payment of the purchase price. The biomass potency was tested and exceeded minimum processing standards. We look forward to utilizing our fully integrated operations to result in the production of isomers.”
Patrick Barry, Chief Investment Officer of One Bad Moon Rising, stated, “We look forward to working closely with Can B as we are very impressed with their fully integrated vertical operations in Colorado. Their facilities in Ft. Morgan and Mead, Colorado, are now capable and ready to process biomass all the way through to isomers. Our network of relationships is seeking isomers, and we are excited to be able fulfill that demand with our new contract with Can B.”
Basher Clowns to be wary of:
Waterchaser
PennyMaster
They want you to sell your shares…
Watch, they will bash relentlessly to get you to sell your shares.
Don’t do it.
Riiiight, not worth the basher pay, but makes for a good laugh, LOL.
Basher Clowns to be wary of:
Waterchaser
PennyMaster
They want you to sell your shares…
Watch, they will bash relentlessly to get you to sell your shares.
Don’t do it.
More Great News from CANB, no wonder Accumulation continues at these Oversold Levels:
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
Can B Corp
Thu, July 20, 2023 at 9:00 AM EDT
In this article:
CANB
Recommendation Rating
Buy
Can B Corp
Can B Corp
Processing Has Already Started
HICKSVILLE, NY, July 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its newly awarded contract with One Bad Moon Rising and purchase of 1.8 million pounds of biomass.
To initially service the contract, Can B purchased 1.8 million pounds of biomass that is ready for immediate processing. The biomass is stored indoors in 1,000-pound supersacks in Ft. Morgan, Colorado (80 miles northeast of Denver).
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are very excited for this new opportunity with One Bad Moon Rising. We were able to purchase the biomass with a market price of $2.7 million by issuing Rule 144 restricted stock in payment of the purchase price. The biomass potency was tested and exceeded minimum processing standards. We look forward to utilizing our fully integrated operations to result in the production of isomers.”
Patrick Barry, Chief Investment Officer of One Bad Moon Rising, stated, “We look forward to working closely with Can B as we are very impressed with their fully integrated vertical operations in Colorado. Their facilities in Ft. Morgan and Mead, Colorado, are now capable and ready to process biomass all the way through to isomers. Our network of relationships is seeking isomers, and we are excited to be able fulfill that demand with our new contract with Can B.”
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online, and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
Yep, Excellent News Release Indeed for CANB $$$$
https://stocks.apple.com/AQtzF3q2UQ3Wct1tG-AbwEg
Congrats to all the new CANB investors, just to name a few, who’s ready for the Next Record Quarter?$$$$$
Welcome aboard
Mr. Walnuts
Count Crypto
Brocool
Badguy3101
Lol, yawn, Minimal volume proves Investors are holding on to these cheap shares.
CANB- 2023 and Beyond
CANB, setting up Nicely for Dollar Plus Run., Smart Money Continues to Load before Next Consecutive Record Quarter is released $$$$$
As for any foolish negative Opinions, it makes for a good laugh.
:
“Lmao. You are nothing more than a paid basher. “
True, a waste of time to bash CANB, couldn't pay one enough.
CANB Ready to POP.
Spot On.
Hogwash. Poor trading habits are nobody's fault but your own. Buy low sell high .. $CANB
Nice, CANB Huge Accumulation the last couple of days. Shares are in strong hands as can be seen by the minimum selling volume today.
Another Record Quarter Headed our way shortly $$$$$
False Noise opinions are getting desperate, lol.
Misleading and outplayed,,the going out of business false opinion has been played out 4 years ago.
CANB Long and Strong
Yep, CANB Huge Accumulation the last couple of days. Shares are in strong hands as can be seen by the minimum selling volume today.
Another Record Quarter Headed our way shortly $$$$$
False Noise opinions are getting desperate, lol.
Correct, but it makes for an interesting laugh. CANB about to Break Another quarterly Record, Loading Continues $$$
:
Paid bashers can't hold $CANB down!
30% Up, it definitely was an Awesome Day for CANB, and to think this is only the beginning. Dollar Land fast approaching.
Stay tune Investors as CANB Continues to Release Record Quarterly after Record Quarter.
Easy to see why no one wants to be on the sidelines before Another Quarterly Record is Released $$$$$$
Wow30%Up today! Strange as it sounds it made a few mad, lol.
Run is just beginning $$$$
Correct Low Float Monster, being Heavily Loaded at this Current Oversold Levels
CANB Continues it’s New climb to Dollar Land.
Looks like the Limited false opinion of dead faded out 2 Years Ago, but it makes for a good laugh.
CANB-2023- And Beyond, Period.
Congrats to Those who have been loading from the .17s and continue! CANB is Just getting Started on this run up to Dollar Land.
Next Consecutive Record Quarter Fast Approaches $$$$$
Spot On, CANB Continues to break Quarterly Records Consistently Back to Back.
No wonder the strong interest by All Parties 24/7.
Correct, CANB is making all the right Moves. No wonder they have released Record Quarter after Quarter.
:
Can B Corp has developed their own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD space.
Yep, CANB looking Strong going into next week. Loading Continues.
CANB Up 40% today! Congrats to all those that have been Loading in the .40 Range last several weeks.
So much for the Opinion Lies of going out of business, wasted time efforts, lol.
CANB continues dish out Record !Breaking Consecutive Quarters, Facts that will keep Investors Buying and Holding Shares.
Nice! CANB Up Over 35% Today! Smart Investors Accumulating and Holding $$$$
Excellent News Release From CANB, No Wonder Nasdaq is on the Horizon $$$$
Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue
Press Release | 04/19/2023
Led by Significant Increase in Duramed
Adjusted EBITDA Loss Decreased by 25% to $2.1 Million
HICKSVILLE, NY, April 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the twelve months ended December 31, 2022.
Key Financial Highlights for 2022
Revenue increased 45% to $6.7 million.
Gross profit decreased 13% to $2.6 million.
Gross margin decreased to 39.1%, due to a higher revenue percentage mix from Duramed.
Adjusted EBITDA loss decreased by 25% to $2.1 million.
Accounts receivable at $6.6 million.
Inventory at $2.0 million.
Total assets at $15.6 million.
Total stockholders’ equity at $2.7 million.
Key Business Highlights for 2022
Solidified and integrated vertical processing capabilities.
Signed Manufacturing and Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.
Consolidated hemp processing operations from Florida and Tennessee to Colorado.
Expanded CBD isolate production into new isomers in expanded Colorado lab.
Expanded durable medical devices to include back support devices for Duramed division.
Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange
Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024, to give the Company an additional window to deploy the capital from the new raise. A key component of the restructuring was the sale of $5.7 million of accounts receivable from Can B’s Duramed Inc. and Duramed MI, LLC divisions to fund payments on two promissory notes for $2.5 million and $1.5 million due to Can B Corp’s largest institutional investor.
Highlight Growth Opportunities
The implementation of the business plan across all three operating divisions will allow the Company to get on a more solid footing for future growth and expansion. Explicitly, some of the new working capital will be used for the installation of existing hemp processing equipment moved in the 4th quarter of 2022 during the consolidation of the Company’s Tennessee and Florida operations into Colorado. The new equipment should come online early in the 2nd quarter of 2023 to begin processing hemp biomass which the Company previously acquired and has in storage. Additionally, the Duramed Division will begin acquiring new medical devices to deploy through its doctor network in New York and Michigan. The white label division currently in the midst of a national roll-out of the Longevity by Brooke Burke Body needs additional processing capacity and will be receiving new equipment in its Lacy, WA operations.
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “2022 was a transition year for us, for as we increased revenue as expected and achieved record annual revenue of $6.7 million, we had to deal with consolidating business and integrating our acquisitions. We are pleased with the position of our business heading into the remainder of 2023.”
Alfonsi concluded, “While we generated an all-time high in annual revenue, we were able to also reduce our cash burn as demonstrated by the 25% decrease in Adjusted EBITDA loss to $2.1 million. Our team made great strides over the past several months integrating and ramping up the various operations. We strategically acquired additional processing equipment to complete our vertical hemp processing capabilities from biomass to crude to distillate to isolate to isomers- all now located in our Colorado operation. We are executing on major strategic agreements, such as Pure Health Products’ deal with Brooke Burke Superfood, and are very excited about the demand and results thus far. As we look forward in 2023, we are enthusiastic regarding the growth opportunities and prospects for our business and are in position for an uplisting to a national securities exchange.”
Financial Results for the Twelve Months Ended December 31, 2022:
Revenue: For the twelve months ended December 31, 2022, revenue was $6.7 million, an increase of $2.1 million, or 45%, compared with $4.6 million for the twelve months ended December 31, 2021. The increase is largely due to an increase in the Company’s Duramed division of $1.8 million due to surgical procedures and healthcare services which enabled the Company to continue to grow within the ultrasound device sales associated with patient recovery.
Gross Profit: For the twelve months ended December 31, 2022, gross profit was $2.6 million, a decrease of $0.4 million, or 13%, compared with $3.0 million for the twelve months ended December 31, 2021. The resulting gross margin was 39.1%, compared with 65.0% for the twelve months ended December 31, 2021, due to higher revenue percentage mix from Duramed.
Total Operating Expenses: For the twelve months ended December 31, 2022, total operating expenses were $16.8 million, an increase of $3.5 million, or 27%, compared with $13.3 million for the twelve months ended December 31, 2021. The increase in operating expenses was primarily due to the non-cash stock-based compensation expense of $7.2 million and $1.4 million of depreciation of property and equipment related to the acquisition of property and equipment via asset purchases.
Operating Loss: For the twelve months ended December 31, 2022, operating loss was $14.2 million, an increase of $3.9 million, or 38%, compared with an operating loss of $10.3 million for the twelve months ended December 31, 2021. Contributing to the increase in operating loss was additional incurred costs to start the Company’s operations in Miami and Tennessee during the first quarter of 2022 and a decrease in the Company’s gross margin due to unforeseen integration issues at the Company’s operations in Miami and Tennessee resulting in the relocation and consolidation in Colorado.
Adjusted EBITDA Loss: For the twelve months ended December 31, 2022, Adjusted EBITDA loss was $2.1 million, a decrease of $0.7 million, or 25%, compared with an Adjusted EBITDA loss of $2.8 million for the twelve months ended December 31, 2021, after deducting a total of $12.1 million in non-cash and one-time expenses, including $9.6 million non-cash stock-based compensation, $1.4 million depreciation, $0.5 million amortization, $0.3 million impairment and $0.3 million loss on sale of property and equipment.
Net Loss: For the twelve months ended December 31, 2022, net loss was $14.9 million, or ($4.18) per share, an increase of $2.8 million, or 23%, compared with a net loss of $1.2 million, or a net loss of ($9.06) per share, for the twelve months ended December 31, 2021. On a per-share basis this loss is a 46% reduction over 2021.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online, and direct. Can B Corp. operates R&D and production facilities in Lacey, Washington, and Florida. To learn more about Can B Corp. and our comprehensive line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Excellent, CANB Continues to make All The Right Moves! Love this part by Management:
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “2022 was a transition year for us, for as we increased revenue as expected and achieved record annual revenue of $6.7 million, we had to deal with consolidating business and integrating our acquisitions. We are pleased with the position of our business heading into the remainder of 2023.”
Alfonsi concluded, “While we generated an all-time high in annual revenue, we were able to also reduce our cash burn as demonstrated by the 25% decrease in Adjusted EBITDA loss to $2.1 million. Our team made great strides over the past several months integrating and ramping up the various operations. We strategically acquired additional processing equipment to complete our vertical hemp processing capabilities from biomass to crude to distillate to isolate to isomers- all now located in our Colorado operation. We are executing on major strategic agreements, such as Pure Health Products’ deal with Brooke Burke Superfood, and are very excited about the demand and results thus far. As we look forward in 2023, we are enthusiastic regarding the growth opportunities and prospects for our business and are in position for an uplisting to a national securities exchange.”
Financial Results for the Twelve Months Ended December 31, 2022:
Revenue: For the twelve months ended December 31, 2022, revenue was $6.7 million, an increase of $2.1 million, or 45%, compared with $4.6 million for the twelve months ended December 31, 2021. The increase is largely due to an increase in the Company’s Duramed division of $1.8 million due to surgical procedures and healthcare services which enabled the Company to continue to grow within the ultrasound device sales associated with patient recovery.
Gross Profit: For the twelve months ended December 31, 2022, gross profit was $2.6 million, a decrease of $0.4 million, or 13%, compared with $3.0 million for the twelve months ended December 31, 2021. The resulting gross margin was 39.1%, compared with 65.0% for the twelve months ended December 31, 2021, due to higher revenue percentage mix from Duramed.
Total Operating Expenses: For the twelve months ended December 31, 2022, total operating expenses were $16.8 million, an increase of $3.5 million, or 27%, compared with $13.3 million for the twelve months ended December 31, 2021. The increase in operating expenses was primarily due to the non-cash stock-based compensation expense of $7.2 million and $1.4 million of depreciation of property and equipment related to the acquisition of property and equipment via asset purchases.
Operating Loss: For the twelve months ended December 31, 2022, operating loss was $14.2 million, an increase of $3.9 million, or 38%, compared with an operating loss of $10.3 million for the twelve months ended December 31, 2021. Contributing to the increase in operating loss was additional incurred costs to start the Company’s operations in Miami and Tennessee during the first quarter of 2022 and a decrease in the Company’s gross margin due to unforeseen integration issues at the Company’s operations in Miami and Tennessee resulting in the relocation and consolidation in Colorado.
Adjusted EBITDA Loss: For the twelve months ended December 31, 2022, Adjusted EBITDA loss was $2.1 million, a decrease of $0.7 million, or 25%, compared with an Adjusted EBITDA loss of $2.8 million for the twelve months ended December 31, 2021, after deducting a total of $12.1 million in non-cash and one-time expenses, including $9.6 million non-cash stock-based compensation, $1.4 million depreciation, $0.5 million amortization, $0.3 million impairment and $0.3 million loss on sale of property and equipment.
Net Loss: For the twelve months ended December 31, 2022, net loss was $14.9 million, or ($4.18) per share, an increase of $2.8 million, or 23%, compared with a net loss of $1.2 million, or a net loss of ($9.06) per share, for the twelve months ended December 31, 2021. On a per-share basis this loss is a 46% reduction over 2021.
About Can B Corp.
CANB up over 20% today again as Accumulation Continues Weekly/Monthly.
The I don’t know how they can continue single opinion was played out 4 years ago.
Facts Now, Investors Patiently waiting for CANB to release its 3rd Consecutive Record Breaking Quarter.
Vision
Patience
Nasdaq
Nice, chart proves the last 2 months has been under heavy Accumulation in the .40 upwards.
Goes to show Investors will not so easily be scared into selling at these Oversold Levels.
Especially with CANBs 3rd Consecutive Record Breaking Quarter approaching fast :)
Patience
Vision
Nasdaq
limited opinion, daily positive volume over the past couple of months proves Accumulation Continues . Congrats to All that have been Loading in the .40-$1.00 Range. All know 3rd Record Breaking Quarter is about to be released.
Eyes on the Prize
Nasdaq fast approaching as well.
Pretty misleading, majority of shareholders have been loading in the .40s, Loading Continues.